Horizontal infundibulotomy needle knife technique for gaining biliary access during endoscopic retrograde cholangiopancreatography SP ASLAM, N HOLT, A THOMSON Gastroenterology and Hepatology Unit, The Canberra Hospital, Canberra, Australian Capital Territory, Australia Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is a technically challenging procedure. Even in experienced hands, failure to achieve deep cannulation of the desired duct may be 10% or greater. If standard biliary cannulation fails, precut techniques, using a needle knife to gain biliary access, are often performed. At least two different precut techniques are well described: the vertical precut technique (VPT) that involves placing the needle tip at the papillary orifice and cutting superiorly (VPT can be done with or without an in situ pancreatic duct stent); and "fistulotomy," in which the needle tip is placed above the papillary orifice and a cut is made in an upward-downward direction without touching the papillary orifice. Comparisons of these techniques by expert endoscopists have revealed similar success rates. Although total complications may not be different, a trend towards a lower rate of post-ERCP pancreatitis in the fistulotomy group has been reported. 1 "Horizontal infundibulotomy" (HI), in which a horizontal cut is made well above the papillary orifice, can also be undertaken, and a series of these cases is here described. Methods: Contemporaneously collected data, in which indications, results, and complications were recorded in 449 ERCPs performed between January 2015 and February 2017 by a single experienced operator, were accessed. Patient records were accessed to identify the use of precut technique, which was only performed if standard cannulation failed. HI was only done if there was a clear border between the ampullary mound and the duodenal wall. After each case, either review in the ward (for inpatients) or telephone contact with the patient or the attending nursing staff was made both on the evening of the ERCP and the next day. Cases in which HI was performed were analyzed. Results: A total of 449 procedures were reviewed; 246 of these had native papillae. Precut needle knife was used in 83 procedures to gain biliary access; 25 of these were via the HI approach and 58 underwent VPT (cutting up from the papillary orifice). HI was found to have a lower rate of failure to access the biliary tree compared with traditional needle knife (21% vs 16%, P = 0.5). In the VPT group, 13 procedures were unsuccessful in gaining biliary tree access. In one of these 13, subsequent HI was used during the same procedure and was successful in gaining biliary access. In those who underwent HI, four procedures (16%) were unsuccessful in gaining biliary access; one of these progressed to a traditional needle knife that was successful in gaining biliary access. Overall, 15 of 246 procedures (6%) with native ampullary cannulations developed post-ERCP pancreatitis. In those who underwent precut needle knife, there was a higher rate of post-ERCP pancreatitis in the VPT group compared with the HI group (10.3% vs 8%, P = 0.8). There was a higher rate of unplanned hospital admissions in the HI group compared with the VPT group (25% vs 10.3%, P = 0.1). Six patients in the HI group had unplanned hospital admissions after the procedure, three for post-ERCP pancreatitis, two with self-limiting pain, and one with a microperforation, who made a full recovery with conservative management. In the VPT group, the only unplanned admissions were in the six patients who developed post-ERCP pancreatitis.
Conclusion:
The HI approach is a relatively safe, alternative way to gain biliary access in difficult procedures, with similar morbidity to traditional needle knife technique.
Introduction: Esophageal food bolus impaction (OFBI) is a common indication for emergent endoscopic intervention. It is unclear from current literature if medical therapy administered in the emergency department reduces the need for endoscopic intervention. Moreover, it is not known if there are certain patient factors that would influence the need for endoscopic intervention. Aims and Methods: A retrospective, multicenter study was performed. The primary aim was to evaluate the efficacy of medical therapy in the management of esophageal meat bolus impaction (OMBI). We also aimed to determine if there were patient factors that influenced response to medical therapy and the need for endoscopic intervention. All cases of OFBI between October 2013 and October 2016 were identified from four participating hospitals, and only cases that involved meat boluses were included to provide standardization to one food type. Univariate and multivariate analyses were performed to identify factors that influenced the need for endoscopic intervention. Results were expressed using odds ratios (ORs) if significance was confirmed on multivariate analysis. Results: A total of 472 patients were included, accounting for 514 presentations with OMBI. There were 355 male patients (75.2%) and 117 female patients (24.8%) with a mean age of 52 years (range, 18-93 years). Medical therapy was administered in 431 presentations (83.9%), with glucagon (67.3%), effervescent agents (49.4%), and glyceryl trinitrate (41.8%) being the most common agents used. A total of 410 presentations (79.8%) required endoscopic intervention. Most procedures were performed outside normal office hours (63%), with a median time to procedure of 5.4 hours (range, 0.22-25.85 hours). To assess factors that resulted in endoscopic intervention, all presentations were included in the analysis. Medical therapy did not appear to reduce the need for endoscopic intervention (OR, 0.97; 95% CI, 0.5-1.87; P = 0.915). Early presentation (< 6 hours) was significantly associated with a reduction in the need for endoscopic intervention (OR, 0.35; 95% CI, 0.21-0.58; P < 0.0001). Previous OFBI symptoms (OR, 2.09; 95% CI, 1.33-3.28; P = 0.001) and older age (OR, 1.02 per year; 95% CI, 1.002-1.03; P = 0.011) were factors associated with increased need for endoscopic intervention. To assess predictors of response to medical therapy, only patients who received any medication were considered. Early presentation (< 6 hours) was again found to be negatively associated with requiring endoscopic intervention (OR, 0.36; 95% CI, 0.20-0.63; P < 0.0001). Previous symptoms of OFBI (OR, 2.17; 95% CI, 1.33-3.55; P = 0.002) and older age (OR, 1.02 per year; 95% CI, 1.002-1.03; P = 0.023) were also found to be factors that predisposed to endoscopic intervention. Surprisingly, glucagon administration was associated with increased need for endoscopic intervention on multivariate analysis (OR, 2.41; 95% CI, 1.37-4.26; P = 0.002). Overall, complication rates from medical therapy were low. There were six cases of symptomatic hypotension with glyceryl trinitrate and two syncopal events. Two cases of post-endoscopy pneumomediastinum were detected on cross-sectional imaging and were managed conservatively. Both cases presented early, and endoscopy was performed within 12 hours. One patient developed hematemesis and melena after endoscopy and was treated conservatively with proton pump inhibitor therapy.
Conclusions:
The majority of patients who presented to the emergency department with OMBI required endoscopic intervention. A period of expectant management may be indicated in patients who are early presenters (< 6 hours). Medical therapy did not reduce the need for endoscopic intervention. Late presenters (> 6 hours) and those with previous symptoms of OFBI should be referred promptly for definitive endoscopic management.
Sensitivity and specificity of biliary brushing cytology: An experience at Wollongong Hospital, New South Wales T DUONG,* Y CHIENG *, † *Wollongong Hospital, and † School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia Aim: To assess the sensitivity and specificity of biliary brushing cytology for the investigation of pancreato-biliary strictures.
Methods:
All patients who had endoscopic retrograde cholangiopancreatography (ERCP) with biliary brushing for cytology at the Wollongong Hospital from January 2009 to November 2016 were reviewed. The cytology results were correlated with biopsy and histopathology results for a minimum of 12 months' follow-up. For analysis purposes, cytology results indicating both suspicious for malignancy and malignancy were considered malignant.
Results: There were a total of 176 patients who met the inclusion criteria. However, 24 patients were excluded from the study due to no clinical data being available on the computerized database or the patient having an unknown clinical outcome. There were 152 patients suitable for analysis. One patient had two brushing cytology results (one negative and one positive) and was included twice in the analysis. Therefore, there were a total of 153 results for analysis. These results are shown in Table 1 . There were 68 cases (44%) of true positive, 25 cases (16%) of true negative, 60 cases (39%) of false negative, and zero cases of false positive results. This gives values of sensitivity and specificity of 53% and 100%, respectively. Pancreatic cancer and inadequate samples (insufficient samples and air-drying or smearing artifact) accounted for 41% and 36% of the false negative cases, respectively. Cholangiocarcinoma, metastatic cancers, gallbladder, and ampullary cancer accounted for the rest of the false negative cases (Table 2) . Conclusion: The retrospective audit performed in this study has shown that ERCP biliary brushing cytology at Wollongong Hospital has similar sensitivity and specificity as that of other centers. More studies are required to investigate the sensitivity and specificity of this technique and to determine ways to improve its use. Despite its limitation on sensitivity of diagnosing malignant strictures, its specificity levels make it a valuable tool for detecting true positive cases of pancreato-biliary malignancy.
High rates of caustic ingestion in migrant populations S EATON, A BUCKLE, A METZ, G HEBBARD, S SOOD Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Victoria, Australia Introduction: Ingestion of caustic substances is uncommon but can result in serious and life-threatening injuries to the gastrointestinal tract, with a reported mortality of 7-14%. Patients often require multiple endoscopic procedures and have a significant health care burden. Methods: We conducted an audit of caustic ingestion at a single tertiary hospital in Melbourne between 2010 and 2015 to evaluate the burden of disease and quality of care and to identify high-risk groups for caustic injury. Patients were identified through case-mix coding, and file reviews were undertaken to collect demographic data and clinical outcomes. A chi-squared test with a P value < 0.05 was considered significant. Results: A total of 38 adults (18 male and 20 female) were admitted for caustic ingestion over 5 years. The median age was 30.5 years (range, 18-85 years). Overall, 61% of cases were due to deliberate ingestion. The most common agents included hydrochloric acid (n = 21, 55%) and sodium hydroxide (n = 6, 16%). There were pre-existing mental health comorbidities in 37% of patients. Two patients (5%) died as a result of their caustic ingestion. Twenty-six patients (68%) required an urgent inpatient gastroscopy, with six (16%) requiring one or more subsequent endoscopies. Thirteen patients (34%) were born in Australia, with the majority born overseas (25, 66%). The catchment area for this tertiary hospital is large and diverse. According to the 2011 census, 36.7% of people in this catchment were born overseas. Using the chisquared statistic, the number of overseas-born people with caustic ingestion was significantly higher than expected (P < 0.001). When migrants from individual countries were analyzed, it revealed disproportionately high rates of caustic injury in those from minority regions. North Africa and the Middle East accounted for seven patients (18%) in our study but only 2.1% of Melbourne's total population. The same was seen with people from Southern and Central Asia, who accounted for six patients (15%) but only 4.4% of Melbourne's census population. Conclusions: This audit highlights a concerning number of caustic ingestion injuries in overseas-born people, who seems to be at greatest risk. There is a need for further investigation and analysis of at-risk groups and mortality rates throughout Victoria. Background: Acute gastrointestinal bleeding (GIB) is a gastroenterological emergency with a mortality rate of 6-13%. 1 Blood transfusion may be lifesaving in patients with massive bleeding. Previous data have shown that a restrictive transfusion strategy is effective in resuscitation in the GIB setting. 2 However, this is controversial in patients with cardiovascular comorbidities. Most patients with GIB can be effectively managed endoscopically within 24 hours of presentation, 3 but this mainly depends on particular resources. Aim: To assess patients who presented with GIB, in relation to the time to having endoscopy and the need for blood transfusion. Methods: The hospital coding database was used to identify patients who presented with hematemesis and/or melena or hematochezia, from July 2015 to July 2016. We extracted data related to patients' demographics, blood results, and procedure-related details from the electronic patients' records. Results: A total cohort of 92 patients who presented to our center with GIB during the 12-month period were found eligible for the study; 42 were female, and the median age was 67 years. The presenting complaints included hematemesis (n = 24), melena (n = 36), hematemesis and melena (n = 19), hematochezia (n = 15), microcytic anemia (n = 13), and syncopal episode (n = 5). Seventy-three patients (79%) presented with a single complaint (hematemesis, n = 22; melena, n = 26; hematemesis and melena, n = 16; and PR bleeding, n = 9). Eighteen patients (20%) presented with two complaints (PR bleeding and anemia, n = 1; melena and anemia, n = 8; PR bleeding and syncope, n = 3; melena and syncope, n = 1; hematemesis and melena and anemia, n = 2; hematemesis and anemia, n = 1; hematemesis and PR bleeding, n = 1; hematemesis and melena and PR bleeding, n = 1), and one patient (1%) had three complaints (melena, anemia, and syncope). Of the 92 patients, 25 (27%) were noted to have a history of heavy alcohol intake, including 15 cirrhotic patients. Twenty-five patients did not have inpatient endoscopy, including nine patients who were stabilized and discharged and had outpatient endoscopy; the other 16 patients did not have endoscopic procedures because of self-discharge (n = 3), private referral (n = 2), transfer to a different hospital (n = 1), or conservative management (n = 10). Considering the inpatient procedures, gastroscopy was performed in 52 patients (78%); five patients had colonoscopy (8%), flexible sigmoidoscopy was performed in three patients (4%), and seven patients had combined gastroscopy and colonoscopy (10%). In the 92 patients who presented with GIB, hemoglobin level (Hb) at time of presentation was below 7 g/dL in 11 (12%), between 7 and 8 g/dL in 17 patients (18%), and more than 8 g/dL in 64 patients (70%). Thirty-eight (41%) of the 92 patients were given blood transfusion, including 14 patients (37%) who had an Hb level above 8 g/dL at time of transfusion. Considering the time to endoscopic procedure in 67 patients who had inpatient endoscopy, 12 patients had their endoscopic procedure in less than 12 hours, including five who were given blood transfusion, and 55 patients had their procedure in more than 12 hours, including 31 who were given blood transfusion (P = 0.354). Furthermore, with assessing the transfusion cohort in the two groups (< 12 hours and > 12 hours to procedure), one out of five and 19 out of 31, respectively, had an Hb level below 8 g/dL at time of transfusion (P = 0.633). The amount of transfused units ranged from 1 to 6 units of packed red blood cells, with an average of 2.5 units per patient. Conclusion: In this study, most of the patients with GIB underwent endoscopic procedures, and more than one third of them had blood transfusions; however, only a small number presented with low Hb levels (< 7 g/dL). There was a trend of giving more red blood cells if the procedure was delayed for more than 12 hours, but this did not reach statistical significance. This might be confounded by the rate and strategy followed for blood transfusion. When we assessed the blood transfusion cause in the second group, there was a trend of giving blood transfusion for Hb > 8 g/dL in the early procedure group, but again, this did not reach statistical significance. The above results may suggest that saving on blood transfusion can be optimized if we use the restrictive transfusion strategy. More prospective studies are warranted to further assess the role of early endoscopic procedure in patients with GIB. Introduction: The use of transcatheter aortic valve implantation (TAVI) has increased in the past decade. The cohort of patients requiring this intervention have a number comorbidities that require appropriate investigation and management. Severe aortic stenosis has been associated with acquired von Willebrand disorder, which can also lead to gastrointestinal bleeding. This study was a retrospective study of 315 patients who had undergone a TAVI procedure at the Prince Charles Hospital (TPCH) between 2008 and 2014. Aims: Our aims were to determine the number of patients who were anemic before their TAVI procedure and to determine whether they had been investigated for a potential cause of gastrointestinal bleeding. Methods: A retrospective audit of 315 patients from the TAVI database was completed to determine the hemoglobin (Hb) levels before the patient's TAVI procedure. Anemia was defined as HB < 120 g/L for males and < 110 g/L for females. A review of their medical records and endoscopy reports was conducted to determine whether the anemic patients had undergone endoscopy, colonoscopy, capsule endoscopy, or small bowel enteroscopy. Pathology records, where available, were also assessed. Results: A total of 87 patients (28%) were found to be anemic. Of those, only 15 (17%) were further investigated with endoscopy, colonoscopy, or both to assess for possible gastrointestinal etiology of anemia ( Table 1) . The common findings of the investigations included diverticulosis, peptic ulceration, gastritis, and esophagitis.
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Conclusion:
A large proportion of patients who undergo a TAVI procedure are identified to be anemic. These patients should be considered for further investigations to determine the cause of their anemia. Background: Esophageal food bolus obstruction (OFBO) is the most frequently encountered esophageal foreign body presentation, with an incidence of 16 per 100 000. Current recommendations of the American Society of Gastrointestinal Endoscopy (ASGE) are based on mostly weak levels of evidence. There remains a paucity of evidence on the management of this important emergency presentation. The role of pharmacological interventions and optimal timing of endoscopic disimpaction is often debated among clinicians. Aim: We aimed to assess the effect of the timing of endoscopic intervention on the safety and effectiveness of the management of OFBO. Methods: We conducted a retrospective analysis of data from emergency admission records, endoscopy reporting software, and patient admission notes between January 2014 and January 2017. Patients who underwent an endoscopic disimpaction within a week of presentation with an OFBO were included. Demographic, history, physical examination, investigations, medications given, anesthesia records, and endoscopic data were recorded. The primary outcome was the safety of early intervention (within 12 hours of onset of symptoms) versus delayed intervention (after 12 hours). The secondary outcome was to analyze the effects of timing of endoscopy on the length of hospital stay as a surrogate marker of efficacy. Result: A total of 97 episodes were identified that met the inclusion criteria during the study period. Of these patients, 54 (55%) were male. Mean age on presentation was 56 years. Steak was the most common food type (37%). Among all patients, 71% were assessed to have complete obstruction. There were 94 patients with a recorded dentition status, among whom 47% had partial or complete dentures. Seventy-four per cent of patients had one or multiple medical treatments (glucagon, hyoscine butylbromide, nitrates, or a fizzy drink) given in the emergency room. Overall, 71% of patients had endoscopic disimpaction within 12 hours of presentation, with a post-procedure complication rate of 5.23%. The other 29% of patients had endoscopic intervention 12 hours or longer after presentation, and 10.81% of these developed complications. Out of a total of seven complications noted, six were deep ulcers, and another was an episode of post-procedure bleeding requiring a repeat endoscopy. Interestingly, all complications were noted following procedures conducted during regular working hours as opposed to after hours. Among patients with complete obstruction, only 59% had endoscopy within 12 hours of presentation. Average length of stay in the patient group with early intervention was 23 hours, while for those in the late intervention group, it was about 32 hours. This difference was statistically significant (P = 0.005). Conclusion: These results suggest a trend towards better outcomes when ASGE guidelines were met. Further larger-scale randomized controlled trials may be required to confirm trends observed in this study.
Use of post-brushing bile aspirate for cytology during endoscopic retrograde cholangiopancreatography improves the diagnostic sensitivity of malignant biliary strictures A GOEL, AKH CHONG Fiona Stanley Hospital, Perth, Western Australia, Australia Background and Aim: Various disorders, both malignant and benign, can cause biliary strictures. The treatment of malignant causes of biliary strictures requires surgery or chemotherapy. There are an increasing number of case reports of benign biliary strictures masquerading as cancers, leading to patients having unnecessary surgery. Accurate diagnosis of the etiology of the stricture is critical to avoid unnecessary operative intervention, its associated complications and mortality. Endoscopic retrograde cholangiopancreatography (ERCP) is often the first therapeutic intervention in patients with biliary strictures, for stent placement to relieve jaundice. Biliary brush cytology is the most commonly used technique to obtain a tissue diagnosis. Even though this technique is highly specific, its sensitivity remains low. We aimed to study the diagnostic performance of post-brushing bile aspirate (PBBA) for cytology, in addition to brushings during ERCP. Methods: Data were obtained from 67 consecutive patients in our unit who had biliary strictures identified on ERCP between March 2016 and March 2017. Bile duct cytology specimens were obtained in a standard fashion using a brush over the wire. After obtaining the brushings, the brush was removed from the sheath. The tip of the sheath was scraped against the stricture with to-and-fro movements to obtain cells. Bile was aspirated through the sheath using a syringe and sent for cytological examination. The final definitive diagnosis of malignant stricture was obtained by biopsy, histology of surgery specimen, endoscopic ultrasound-guided fine needle aspiration, or by clinical progression. Twelve patients were excluded, as they either had indeterminate strictures or bile aspirate was not obtained during the procedure. Results: A total of 55 patients (34 male and 21 female) with a median age of 75 years (interquartile range, 61-80 years) were included. Of these, 41 patients had malignant strictures (23 pancreatic, 11 cholangiocarcinoma, five metastatic disease, and one ampullary carcinoma), while 14 patients had benign strictures on final evaluation. For brush cytology alone, the sensitivity was 36.5%, with a negative predictive value (NPV) of 35%. When PBBA cytology was combined with brushings, the sensitivity was significantly higher, at 51.2% (P < 0.05), with an NPV of 41.2%. The specificity and positive predictive value were 100% for both methods. No complications occurred while obtaining PBBA. Conclusions: PBBA cytology, in addition to bile duct brushing cytology, significantly increases the sensitivity in diagnosing malignant bile duct strictures. In our cohort of 67 patients, we were able to diagnose six additional cancers by introducing PBBA cytology, alleviating the need for repeat procedures or further investigations (endoscopic ultrasound-guided fine needle aspiration) to establish a tissue diagnosis. PBBA is a safe, rapid, and inexpensive method to obtain additional cytology specimens. Once the stone was visually confirmed, the laser fiber was placed onto the stone, and short bursts of energy were applied to achieve fragmentation. Stone fragments were then removed with ERCPdirected balloon or basket. If required, treatments were repeated to achieve complete ductal clearance.
Results: A total of 18 patients (10 male and eight female) underwent POC-guided laser lithotripsy (15 biliary and three pancreatic). The mean age was 69 (21-87) years. Associated comorbidities included primary sclerosing cholangitis (2), pyogenic cholangitis (2), and chronic pancreatitis (3). Patients required a mean of 1.7 (range, 1-4) earlier attempts to remove stones at ERCP, including preceding endoscopic sphincterotomy ± sphincteroplasty. To clear stones, three patients required two lithotripsy procedures (two biliary and one pancreatic). Stones were cleared in all patients (Table 1) . Laser power settings were higher for pancreatic stones (pancreatic, 8-30 W vs biliary, 8-10 W). Complications were mild: aspiration pneumonia (2) and pancreatitis (1) from 21 procedures. There were no ductal injuries. Conclusion: Cholangiopancreatoscopy-guided Ho laser lithotripsy appears to be safe and very effective at treating difficult biliary and pancreatic stone disease. Further studies are required.
Diagnostic yield of endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions N HOLT, P ASLAM, V AGGARWAL Canberra Hospital, Canberra, Australian Capital Territory, Australia
Background: Endoscopic ultrasound (EUS) is regarded as the most appropriate modality for tissue acquisition for pancreatic lesions. It has similar specificity to computed tomography-guided percutaneous biopsy, but higher sensitivity and a lower rate of peritoneal carcinomatosis. [1] [2] [3] In recent years, the question of sample type has come to the fore. 4 Core biopsies (EUS-fine needle biopsies [EUS-FNB]) allow for analysis of histological architecture rather than just cytology, gathered with fine needle aspiration (FNA), potentially at the cost of increased risks with the larger needle. There is no convincing evidence that EUS-FNB has an increased diagnostic accuracy compared with EUS-FNA. 5, 6 The standard of care for pancreatic lesions in most centers is FNA with rapid on-site cytopathology, which improves diagnostic yield by 10-15%. 7 This arrangement is not costeffective and may not always be available. One review showed EUS-FNB without on-site cytopathology has a similar accuracy to EUS-FNA with it, but this was not replicated in other studies. 8, 9 One study demonstrated that increasing the number of FNA "passes" to a minimum of seven can ameliorate the need for on-site cytopathology without reducing diagnostic accuracy or increasing risk.
10 EUS-FNB theoretically requires fewer "passes" for tissue acquisition, potentially resulting in fewer complications, but this has not been established in the literature. With the above in mind, we reviewed current practices at a single center to determine if our standard method of EUS-FNA with on-site cytopathology was adequate for diagnosis of solid pancreatic lesions. Aim: We conducted a retrospective review of patients who underwent an EUS-guided FNA of a pancreatic lesion at a single tertiary center in Australia, with rapid on-site cytopathology. We looked at the outcomes of diagnostic yield and number of passes required to attain tissue. Methods: Ethics approval was sought from ACT Health's Low Risk SubCommittee. Data were collected from hospital records of patients who underwent an EUS-FNA between January 2014 and December 2016. A total of 72 procedures were performed, all by a single experienced operator, using the Cook 25G EchoTip Ultra Endoscopic Ultrasound Needle, with on-site real-time cytopathology. Results: The total number of solid pancreatic mass lesions was 72, with a diagnostic yield of 89% and a mean of 3.2 passes. Of the samples, 53 were malignant, 11 benign, and eight indeterminate or unclear. Of the eight indeterminate samples, all but one attained pancreatic cells, but the yield was either too paucicellular (n = 2) or had only subtly atypical cytology, inadequate for diagnosis (n = 5). Three of these patients were lost to follow-up, with the other five ultimately diagnosed with a pancreatic malignancy. One proceeded to surgery on the basis of a dotatate PET scan and one developed obstructive jaundice and was diagnosed with metastatic pancreatic cancer on imaging. The remaining three patients had a subsequent tissue diagnosis made: one via laparoscopic biopsy, one via a repeat EUS with FNA intraoperatively, and one on a concurrent ampullary biopsy at the time of their original EUS. Conclusion: The diagnostic accuracy of EUS-guided FNA with on-site cytopathology was comparable to the current available literature and on par with the reported diagnostic accuracy of EUS-FNB. The average number of passes required to gain diagnostic tissue was only 3.2, which is lower than the acceptable standard. On the basis of the published literature rates, this suggests that with current evidence, there would be no benefit in routine use of cutting needles at our center at this time. Introduction: There have been few significant advancements in the technique of endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) since its inception. Rapid onsite evaluation (ROSE) by an in-room cytotechnician maximizes EUS-FNA diagnostic yield and represents the current gold-standard technique. However, even with ROSE, diagnostic yield can be as low as 78%, and the tissue acquired is often not adequate for assessment of tissue architecture and cellular morphology that is essential for the diagnosis and classification of lesions such as stromal tumors and lymphomas. ROSE is not universally available and incurs significant additional costs. EUS-guided fine needle biopsy (FNB) does not require ROSE and provides histological samples that retain tissue architecture. A recently developed 20-gauge (20G) FNB needle has been designed to acquire true core biopsies, while still being technically feasible in challenging anatomical locations. No studies have been published to date assessing the performance characteristics of this core biopsy needle. This study aims to compare the diagnostic yield of standard FNA plus ROSE versus FNB using the recently developed 20G needle without ROSE. Secondary endpoints included the ability of FNB to provide additional diagnostic information, its technical feasibility, and safety. If FNB proves to be equivalent to FNA + ROSE, FNB alone could become the new standard of care, with practice-changing benefits. These include use in centers without availability of ROSE, eliminating the costs associated with ROSE, and the provision of diagnostic information not available via standard FNA, including tissue architecture, tumor grade, and identification of specific markers required for the selection of targeted molecular therapies for certain malignancies. Methods: A prospective database was retrospectively interrogated to identify patients who had undergone both FNA and FNB in a single procedure for the diagnosis of mass lesions greater than 20 mm in size at two tertiary referral institutions. FNA was performed as per standard technique using 19, 22, or 25G Cook EchoTip Ultra FNA needles. All FNA samples had ROSE performed by a cytotechnician. Core biopsy of the same lesion was performed using the 20G FNB needle at the same procedure and placed into formalin by the endoscopist. Diagnostic yield, histology, immunohistochemistry (IHC), and additional parameters (e.g., mitotic rate and molecular markers) were compared. Both modalities were also compared with gold standards of surgical pathology or clinical/imaging follow-up. P values of < 0.05 were considered statistically significant. Results: Thirty-two patients underwent FNA and FNB at the same procedure; 16 (50%) were male, mean (SD) age was 64.6 ± 12.2 years. Thirtytwo lesions were sampled; 17 (53.1%) were pancreatic, median (SD) lesion size (maximum diameter) was 33.4 ± 12.1 mm. The diagnostic yields of FNA and FNB were 87.5% and 84.4%, respectively (P = 1.0). The mean number of needle passes was 3.4 ± 1.0 for FNA, and 1.3 ± 0.8 for FNB (P < 0.001). In 15 cases (46.9%), FNB provided additional diagnostic information, including tumor proliferation rate, tumor differentiation, tumor grade, IHC identification of the primary tumor, classification of specific spindle cell tumor type, and histological classification of lymphoma type. The FNB needle did not pose any technical difficulties at any anatomical location, including the 12 cases (37.5%) that required a transduodenal approach to sample a pancreatic lesion. No adverse events directly attributable to either the FNA + ROSE or FNB techniques were encountered. Conclusion: FNB using a new 20G core biopsy needle has equivalent diagnostic yield to the current gold standard of FNA + ROSE. Fewer needle passes and superior additional diagnostic information were obtained using the FNB needle. Technical success was achieved at all anatomical locations. This study suggests that FNB alone could become the new standard of care for EUS tissue sampling, obviating the personnel, economic, and time costs associated with FNA + ROSE. Superiority is also suggested, with the core biopsy being able to provide histology instead of cytology alone, tumor classification, and additional important molecular markers required for targeted molecular therapies for malignant lesions.
Predictive factors and rate of positive endoscopic retrograde cholangiopancreatography findings following an abnormal intraoperative cholangiogram for choledocholithiasis YH KIA,* J SANSOM,* K SIMONS, ‡, § A MOSS negative ERCP findings, representing a significant proportion of patients exposed to potential morbidity and risks related to an ERCP. There are limited Australian data on this question. This study aimed to identify the predictive factors and rate of positive ERCP findings following an abnormal IOC in our cohort. Methods: We conducted a retrospective study of patients who had abnormal IOC findings during laparoscopic cholecystectomy and who went on to have postoperative ERCP between 2012 and 2016 at our center.
Results: A total of 127 patients were included in our study; 91 (72%) were female. The mean age of patients was 50 years (range, 17-95 years). There were 24 IOCs (19%) done externally and referred to our center for ERCP. IOC findings were as follows: 115 patients (91%) had filling defect(s) in the common bile duct, 40 patients (31%) had a dilated intrahepatic and/or extrahepatic biliary system, and 29 patients (23%) had non-passage of contrast into the duodenum. Five patients (4%) had other IOC findings (four with filling defect in the common hepatic duct, one with filling defect in the cystic duct). Liver function test results included the following: 98 patients (77%) had elevated alanine aminotransferase levels, 81 patients (64%) had elevated aspartate aminotransferase levels, 86 patients (68%) had elevated alkaline phosphatase levels, 117 patients (92%) had elevated gamma-glutamyl transferase levels, and 40 patients (31%) had an elevated bilirubin level. Forty-six patients (36%) had further imaging after IOC but before ERCP. The median duration between IOC and ERCP was 3 days. Overall, 111 patients (87%) had positive ERCP, and 16 patients (13%) had negative ERCP. A conditional inference tree analysis was performed, and there was no evidence of any relationship between the pre-ERCP factors and the outcome of the ERCP. Conclusion: There do not appear to be any significant predictive factors of positive ERCP in our patient cohort. This finding is potentially limited by the small sample size and retrospective nature of the study; however, it is consistent with other international studies. As such, no factors can be reliably used to guide management and predict the outcome of ERCP following an abnormal IOC. Interestingly, our rate of positive ERCPs following abnormal IOCs (87%) was higher than international studies, and this may be attributed to other factors such as the experience of our surgeons in correctly interpreting the IOC findings, which are more difficult to measure. More prospective controlled studies are required to further evaluate this study question. In a center where the positive ERCP rate is high after an abnormal IOC, it is reasonable to proceed directly to ERCP rather than investing unnecessary time and resources in further non-invasive tests.
Learning curve for endoscopic submucosal dissection of gastric neoplasms: Low-volume single-center experience ST KIM, SY NA, SJ KOH Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea
Introduction: Endoscopic submucosal dissection (ESD) has become a standard therapy for early gastric neoplasia. There is no consensus yet about the number of experiences required for performing ESD alone. Aims: To investigate the learning curve of ESD 1,2 performed by a single beginner endoscopist focusing on developing the performance of dissection, shortening the procedure time, and preventing complications. Methods: Records of 120 consecutive ESD procedures performed by a single beginner endoscopist with an ESD knife from March 2012 to February 2016 were collected. For analysis of the learning curve, total procedures were divided into four periods, each comprising 30 sequential ESDs. The parameters assessed were the en bloc resection rate, complete resection rate, procedure time, and related complications. Results: In the procedure time according to the number of experiences, the procedure time decreased from 30 experiences. However, there was no statistical difference from the first (63.5 ± 54.0) to the second quarter (44.5 ± 31.4, P = 0.19), to the third quarter (40.7 ± 27.8, P = 0.08), and to the fourth quarter (40.8 ± 23.1, P = 0.09). There was no procedure that exceeded 100 minutes from the third quarter. There was a total of seven perforations, four of which were in the first quarter, two in the second, and one in the third. In the procedure time according to the locations of the lesions, upper third lesions (92.0 ± 43.7) showed longer procedure times than middle (46.6 ± 40.2, P < 0.01) and lower third (39.5 ± 27.5, P < 0.01) lesions, with a statistically significant difference. In addition, in the fibrotic lesions, regardless of size and location, all took a very long time, more than 100 minutes. Conclusion: It needs accumulated experience with the help of a professional expert for up to 30 cases, and, to achieve the more advanced level, about 90 procedures are needed. The location of the lesion is the important factor in determining the difficulty of the procedure. Therefore, it is best to avoid upper third lesions as far as possible until experience of 90 cases or at least 30 procedures. Introduction: Small intestine polyps are uncommon, and, similar to other regions in the gastrointestinal tract, these lesions can be premalignant or malignant.
1 They are usually visualized in the first and second part of the duodenum. These lesions are generally biopsied for further histopathological evaluation.
2 Endoscopic resection can be challenging due to complications such as perforation. 3 The "target sign" is useful for identifying perforation and consists of a bullseye (concentric circular) image in the submucosal area on the specimen's inner face. 4 We report an unusual entity presenting itself as a sessile polyp in the bulb, which was submitted to endoscopic resection and presented a false target sign. Case Report: A 63-year-old man with Barrett's esophagus underwent his regular surveillance endoscopy. Incidentally, there was a 10-mm sessile polyp in the duodenal bulb (Figure 1) . The lesion was lifted with submucosal injection and resected entirely. On inspection of the resection base, there was a mirror target sign (Figure 2) . Examination of the resected specimen revealed the target sign ( Figure 3 ). As such, the endoscope was reinserted and the base closed with two endoscopic clips. The patient was clinically well, tolerated diet immediately postprocedure and did not require hospital admission. Microscopic examination of the resected polypoid lesion demonstrated a multilocular cystic lesion predominantly in the submucosa and muscularis mucosae (Figure 4) . The cyst was lined by cytologically bland columnar and focally flattened mucin-secreting cuboidal epithelium. The lining epithelium was free of dysplasia or adenomatous elements and merged with adjacent Brunner's glands. Discussion: Despite signs that were found on both the specimen and base of the resected region, there was no evidence of muscularis propria on the specimen. Although we should consider the possibility of muscular injury when the target sign is found, this case demonstrates that a false target sign can occur. The false target sign has been reported with an adenoma developing on a lipoma in the colon. In this instance, an adenoma-like lesion developed on a cyst. Clinically, it is indeed difficult to judge what needs to be done when faced with a situation such as this. Caution and closure of the defect are advised.
Competing interests: None. Background and Aim: Benign tumors of the ampulla of Vater are rare, but the majority have malignant potential. Surgical resection was traditionally considered the standard of care; however, endoscopic ampullectomy is a minimally invasive alternative. Only a few case series have been published, with relatively small sample sizes and short follow-up. This study aims to retrospectively evaluate the safety and efficacy of endoscopic ampullectomy in a single tertiary referral center over a 10-year period. Methods: All patients who underwent endoscopic ampullectomy were identified through the hospital endoscopy and pathology databases and included in this study. The medical records were retrieved and reviewed with an extensive questionnaire. The data points analyzed included patient details, lesion characteristics, efficacy, adverse outcomes, and recurrence rates.
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Figure 2
Resection base with suggestion of muscular layer injury.
Figure 3
Target sign on resected lesion.
Figure 4
The lining columnar epithelium of the multilocular cyst (left portion of the microphotograph) is similar to the normal Brunner's gland epithelium. The overlying duodenal mucosa shows some villous distortion (hematoxylin and eosin stain). 
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Results: A total of 53 ampullectomies were performed on 26 female and 27 male patients with a mean age of 64 years (range, 35-88 years). Patients with familial adenomatous polyposis (FAP) (n = 14) were significantly younger than those with sporadic lesions (n = 39) (51 vs 69 years; P < 0.001). Ampullary tumors were most commonly detected during surveillance endoscopy in FAP patients (P < 0.001), followed by incidental discovery in patients without FAP who were investigated for abdominal pain (P = 0.01). Pre-ampullectomy assessments included side-viewing endoscopy and biopsies in all patients, endoscopic ultrasound in 36%, and magnetic resonance cholangiopancreatography in 19% of patients. The mean ampullary lesion size was 20 mm (range, 6-50 mm) and in 37 patients was confined to the ampulla. A lateral spreading tumor of the papilla (LST-P) was present in 16 patients. Lesions were resected en bloc when possible (57%), and the pancreatic duct was stented if feasible as prophylaxis against pancreatitis (83%). In addition, biliary sphincterotomy was performed in 28% of patients to mitigate the risk of cholangitis. Endoscopic resection was performed successfully in all patients. Histological review of the resected specimens showed lowgrade dysplasia (40.4%), high-grade dysplasia (44.2%), intramucosal carcinoma (3.8%), and gangliocytic paraganglioma (1.9%). Invasive adenocarcinoma was identified in five patients (9.6%), who were referred for surgery. Histological concordance with initial biopsy was 58.5%, while upstaging occurred in 37.7%. Mean length of hospital stay was 5.5 days. Complications were observed in 10 patients (18.9%), consisting of early (< 48 hours) hemorrhage (11.3%), moderate pancreatitis (1.9%), retroperitoneal perforation (1.9%), and delayed papillary stenosis (3.8%). Female sex (P < 0.01) and advanced age (P < 0.05) were associated with development of complications. Follow-up was managed in 85% of patients over a mean of 31 months. Persistent residual adenoma was present in three patients, and recurrence occurred in four patients (8.9%) at an average of 16.3 months. LST-P lesions were found to have a greater risk of recurrence (P < 0.05) compared with lesions confined to the ampulla. Four patients required surgery for endoscopically unmanageable persistence or recurrence. The overall curative resection rate was 90.2%, achieved at an average of 1.3 procedures. Conclusions: This study substantiates that endoscopic ampullectomy is a safe and highly efficacious procedure for managing non-invasive ampullary tumors. Aside from its therapeutic utility, endoscopic resection confers the additional benefit of assessing the true histological diagnosis of the tumor, which has implications for prognosis and further management. A structured approach to initial lesion assessment, endoscopic treatment, and surveillance is required to ensure the best outcomes in patient safety and clearance. This study aimed to determine the impact of implementation of a new ERCP service on procedure volume in a high-volume, predominantly ambulatory endoscopy unit. Before implementation, all inpatient ERCPs required ambulance transfer to a second endoscopy unit. Methods: A retrospective audit was conducted of the introduction of an ERCP service within a two-room, high-volume academic endoscopy unit. All ERCPs were performed within normal working hours and by consultant gastroenterologists who were additionally performing ERCP at other centers. Activity data were obtained from the electronic scheduling and reporting databases for the first 12 months of the ERCP service and the 12 months prior. Additional patient and outcome data were collected from review of the electronic record and medical chart. Patient demographics, ERCP indication, success/outcome, and 30-day adverse events were recorded. Only activity from routine endoscopy sessions (20 lists per week in two rooms) was included; additional evening lists commenced in 2016 were excluded. Results: A total of 6858 procedures were performed on 5064 patients from March 2015 to February 2016. After ERCP was introduced, 7904 procedures were performed on 5827 patients from March 2016 to February 2017 (Table 1) . Excluding ERCP procedures, there was a total increase of 973 endoscopic procedures (14%) in the second 12-month period. These endoscopy procedures were all performed during routine endoscopy sessions and not during extended hours or after hours. A total of 73 ERCPs were performed on 57 patients (26 male and 31 female) with a mean age of 57 years (range, 20-99). Most procedures were performed for inpatients (60, 82%) with choledocholithiasis being the most common indication (55, 75%). Deep sedation was used in 66 patients (90%), with the remainder performed under general anesthesia. The successful cannulation rate in those with a native papilla was 94% (47/50); successful cannulation was achieved in all patients on repeat ERCP. There was one case of mild post-ERCP pancreatitis; this patient had received rectal indomethacin. Clinically significant post-sphincterotomy bleeding requiring a transfusion occurred in one patient 1 week after ERCP, after being re-anticoagulated following ERCP. There was no ERCP-related mortality. Conclusion: A new ERCP service can be successfully and safely implemented within a high-volume endoscopy unit, without a negative impact on overall endoscopy activity. The increase in endoscopy activity beyond ERCP reflects efficiency gains during routine endoscopy sessions, as additional hours or lists were not created and no procedures were performed outside normal hours.
Upper gastrointestinal bleeding in hip fracture patients: A single tertiary center experience J LIU,* R GUPTA, *, † C PULLE,* T RAHMAN, *, † S PANDY* *Centre for Service and Quality Improvement, Department of Gastroenterology and Hepatology, Prince Charles Hospital, and † School of Medicine, University of Queensland, Brisbane, Queensland, Australia Background: Osteoporotic hip fractures are an important cause of morbidities and mortality in the elderly population. This group of patients are usually frail and have multiple medical comorbidities that put them at high risk of postoperative complications. One of the complications is acute upper gastrointestinal bleeding (UGIB). The prevalence of perioperative acute UGIB is estimated in the literature to be 1% to 15%. Aim: This study aimed to 1 Identify the incidence of perioperative acute UGIB in our hip fracture patients; , 83 ± 8 years) . The average length of stay was 13 ± 6 days. Mortality rates were 18% at 30 days and 36% at 1 year. Gastroscopy was performed in 10 patients (91%), with a bleeding source identified in seven (70%), and of those, five were amenable to endoscopic intervention. Two patients received injection and thermal therapy; two patients received injection, thermal, and mechanical therapy; and one received mechanical therapy alone. One patient did not undergo gastroscopy due to intercurrent illness and subsequently died from her intercurrent illness. Pre-existing peptic ulcer disease was identified as a risk factor for acute UGIB (odds ratio, 7.9; P = 0.037). Conclusion: Our study reported a very low incidence of UGIB in hip fracture patients. Despite being a high-risk population, timely endoscopic evaluation can be safely undertaken, thereby optimizing patient outcome. When risk factors such as history of peptic ulcer disease are present, additional precautions, including gastro-protective agent and nutritional support, should be undertaken.
Is needle knife sphincterotomy a safe and effective tool in malignant cases? V NAVANI,* J BORCHARD, † T LEE,* H CHIENG* *Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, †
Department of Research Statistics, Wollongong Hospital, Wollongong, New South Wales, Australia
Aim: Needle knife sphincterotomy is an intervention used during endoscopic retrograde cholangiopancreatography to gain selective biliary cannulation. The presence of a pancreato-biliary neoplasm is thought to be a risk factor for failure to achieve selective biliary cannulation. Our study aimed to assess whether needle knife sphincterotomy aids in selective biliary cannulation, especially in malignancy. Methods: We performed a retrospective cohort analysis of 120 consecutive procedures, involving only naive duodenal papilla. Outcome measures were success at selective biliary cannulation and adverse event rates. Results were assessed using chi-squared and logistic regression. Results: Needle knife sphincterotomy success rates during the initial procedure were higher in malignant cases (77.4%, 24/31) compared with nonmalignant cases (52.6%, 40/76; P = 0.017). Regression showed an odds ratio of 3.742 (P = 0.01) for a malignant case attaining selective biliary cannulation at first attempt. In malignant cases, success was gained in 83.9% of cases (26/31) by the second attempt, a similar outcome to non-malignant cases (82.9%, 63/76). The overall adverse event rate was 6.5% (2/31) for malignant cases and 14.5% (11/76) in non-malignant cases. The adverse event rate in malignant patients for each individual adverse event was lower than non-malignant cases. Conclusion: Our study showed good outcomes with needle knife sphincterotomy in malignant cases, especially at the first attempt. Furthermore, it is a well-tolerated intervention, with comparable adverse event rates to the non-malignant cohort. Needle knife sphincterotomy should be considered for difficult cases, especially in the malignant setting.
Eosinophilic esophagitis: A common cause of food bolus obstruction in adults JF NG, KL COLLINS, D DOWLING Department of Gastroenterology, University Hospital Geelong, Geelong, Victoria, Australia Background: Recent studies have shown an increased prevalence of eosinophilic esophagitis (EO) as a cause of food bolus obstruction. Increasing awareness of this condition, as well as a reduction in peptic-related strictures, has shifted the epidemiology of food bolus obstruction in the past decade, with a reduction in the age of patients at presentation. 1 However, most current studies of EO in the food bolus obstruction cohorts are based on retrospective data, and thus, prevalence is likely underestimated, as not all presenting patients were biopsied on index endoscopy. Aims: To prospectively evaluate the prevalence of EO in an adult population presenting with food bolus obstruction in a tertiary hospital. Methods: Patients who were referred to the University Hospital Geelong Gastroenterology Unit for endoscopic removal of food bolus obstruction from January 2014 to February 2017 were included in this study. Random esophageal biopsies for histology were taken during index endoscopy of all patients presenting with food bolus obstruction unless there was an obvious cause seen on endoscopic examination (e.g., malignant strictures and known benign strictures). Patient characteristics and endoscopic and histological findings were analyzed. Results: A total of 69 patients were referred to the unit with food bolus obstruction during this period. Biopsies were obtained for all 57 patients who did not have another obvious cause found on endoscopy. The mean age for the whole food bolus cohort was 61 years. Eleven patients (16%) had histological findings consistent with EO. The mean age for the patients with EO was 39 years. Ten of the patients with EO had macroscopic appearance of EO on gastroscopy. Only two of the 11 patients with EO had a history of atopy. Conclusion: This study again highlights EO as an important cause of food bolus obstruction, especially in the younger population. Most patients with EO have macroscopic appearance suggestive of the condition, but this does not preclude biopsies in those without these features of this treatable condition. Methods: Patients referred for EUS-guided biopsy of peri-gastrointestinal lesions, with size > 1 cm, were prospectively recruited. Each lesion was biopsied by one pass of the 20G FNB and one pass of the 22G FNB needle, in a randomized order. Without on-site cytology assessment, the specimens were flushed into formalin for histological assessment. Final diagnosis was based on positive histology or at least 9 months of follow-up in cases with a negative biopsy. Outcomes were diagnostic performance, tissue quality, and complications. Results: A total of 136 EUS-FNB passes (20G, 68 vs 22G, 68) were performed in 68 patients for investigation of 47 pancreatic masses, 15 lymph nodes, and six submucosal lesions. For both needles, 100% technical success was achieved, with no immediate complication. After 18 ± 7 months of follow-up, histological diagnosis was established in 66/68 patients (97%) (pancreatic cancers, 36; gastrointestinal stromal tumor, 6; autoimmune pancreatitis, 3; neuroendocrine tumors, 3; sarcoidosis, 3; metastatic nodal disease, 3; cholangiocarcinoma, 2, pancreatic lymphoma, 1; schwannoma, 1; leiomyoma, 1; and reactive node, 7). The diagnostic accuracy was similar between the needles (20G, 96% vs 22G, 94%), with only two cases that were non-diagnostic by both needles. Histological cores were observed more frequently with 20G than 22G FNB needles (91% vs 81%; P = 0.04). Conclusion: Without on-site cytology, EUS-guided tissue acquisition with FNB needles achieves high diagnostic yield (97%). Although there are no differences in technical success, diagnostic yield, or complications between the 20G FNB and 22G FNB needles, the 20G FNB needles acquire more histological cores.
Comparison of diagnostic
Stereotactic ablative radiotherapy using endoscopic ultrasound-guided fiducial placement for locally advanced pancreatic cancer: Early experience in a tertiary center V-A PHAN,* H LE, † N SINGHAL, ‡ N NGUYEN* Departments of *Gastroenterology, † Radiation Oncology, and ‡ Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Background: Evidence supporting radiotherapy in locally advanced pancreatic cancers (PDACs) has been limited due to the lack of ability to deliver radiation to the PDAC without toxicities to surrounding organs. Stereotactic ablative radiotherapy (SBRT), using endoscopic ultrasound (EUS)-guided fiducial marker placement, has been increasingly used for locally advanced PDAC, but its efficacy remains unclear. Aims: To evaluate the outcomes of SBRT, alone or in combination with standard chemotherapy, for locally advanced PDAC. Methods: Patients with locally advanced PDAC were recruited for SBRT, with or without conventional chemotherapy. In all patients, capecitabine was given 2 weeks before SBRT as a radiosensitizer. For patients who received chemotherapy, eight cycles of FOLFIRINOX were given before SBRT. Outcome data were prospectively collected. Results: A total of 21 patients were treated by SBRT; 13 had SBRT alone and eight had combined chemotherapy-SBRT. All had an ECOG status of ≤ 2 and completed the given capecitabine and/or FOLFIRINOX. EUSguided fiducial placement was successful in 100% of cases, with no immediate or long-term complications. After 13 ± 8 months of follow-up, 12/21 patients (57%) had reduction in tumor size of > 50%, three (14%) had stable disease with no changes in size, and four (19%) had progression of disease (all of whom had only SBRT) (see Table 1 ). SBRT was very well tolerated, with only minor toxicities (pain, 19%; duodenal ulcer, 5%). As expected, FOLFIRINOX chemotherapy was associated with a high rate of toxicities, including diarrhea (40%), fatigue (50%), nausea (50%), and neutropenia (50%), which settled by the time of SBRT treatment. Conclusions: Our preliminary data suggest that SBRT with EUS-guided fiducial placement is safe, effective, and well tolerated, even when combined with FOLFIRINOX chemotherapy. Given that the majority of patients had good treatment response, with > 50% reduced tumor size, the role of SBRT in combination with chemotherapy warrants further evaluation in a multicenter, randomized trial. with FBO, 199 (80.6%) had evidence of impacted food bolus in the esophagus on endoscopy, and 48 patients (19.8%) had spontaneous passage of food bolus. Of those with impacted FBO, 93 had capassisted technique and 106 had a conventional approach, with no differences in the type and location of food bolus. The success rate of cap-assisted technique (100%) was comparable with that of conventional techniques (97.5%; P = 0.25). Patients who had a failed extraction by conventional techniques (n = 3) were successfully treated when switched to the cap-assisted approach. Cap-assisted approach was associated with a shorter total procedural time (34 ± 8 vs 43 ± 22 min; P = 0.006), a shorter length of hospital stay (22.72 ± 13.33 vs 37.84 ± 32.55 hours; P = 0.0017), and more en bloc removal (87.3% vs 22.8%; P < 0.001). There were more complications in the conventional group than the cap-assisted group (7/106 vs 0/93; P = 0.01). Conclusion: Cap-assisted technique is 100% effective in the management of impacted FBO in the esophagus, with a significantly shorter procedural time and no complication. Although the findings suggest that cap-assisted technique should be the first-line technique in the management of esophageal FBO, further evaluation with a randomized multicenter trial is warranted. Introduction: There are several risk-scoring systems available to assist in the management of upper gastrointestinal bleeding (UGIB). The aim of this study is to compare the performance of pre-endoscopy Rockall score (pre-RS), post-endoscopy Rockall score (post-RS), Glasgow-Blatchford score (GBS), and AIMS65 score in predicting the need for interventions and outcomes in patients admitted to hospital for UGIB. Methods: Data related to the three scoring systems were collected prospectively, and scores were calculated in consecutive patients admitted with acute UGIB to the Royal Adelaide Hospital over 24 months. The performance of these scores, using operating characteristic (ROC) curves, in predicting the following outcomes was assessed: the need for endotherapy, rebleeding risk, transfusion requirement, surgical intervention, and death. All patients received high-dose acid suppression therapy. Results: Of the 777 patients (491 male; 66.4 ± 0.6 years) who presented with UGIB, 622 (402 male; 65.7 ± 0.6 years) underwent endoscopy, with 123 (38%) requiring endoscopic therapy, 42 (13%) repeated endotherapy, and 12 (3.7%) surgery for hemostasis. There were 155 patients (89 male; 68.8 ± 0.6 years) who were treated conservatively due to being medically unfit (n = 50), having a low suspicion (n = 25), a known diagnosis (n = 17), and suspected Mallory-Weiss tear (n = 28). Death occurred in 33 patients (8%); 10 deaths (2.4%) were related to bleeding. Patients who required endoscopic or surgical intervention had higher GBS, pre-ERS, post-ERS, and AIMS65 scores (P < 0.001). On ROC analyses, GBS and post-RS scores were superior to pre-RS and AIMS65 scores in predicting the need for endotherapy (AUC, 0.75 and 0.78 vs 0.65 and 0.59; P < 0.01), repeated endoscopy due to rebleeding (AUC, 0.66 and 0.65 vs 0.56 and 0.60; P = 0.03), and blood transfusion (AUC, 0.83 vs 0.72 and 0.70; P < 0.01). The scoring systems performed equally well in predicting the need for surgery (GBS vs Rockall vs AIMS65: AUC, 0.72 vs 0.67 vs 0.71) and death (AUC, 0.75 vs 0.72 vs 0.69). Conclusions: Although GBS performs equally well for predicting death and need of surgery, it is superior to both Rockall and AIMS65 scores in predicting the need for endotherapy, repeated endoscopy, and blood transfusion in patients with acute UGIB. These findings suggest that GBS is the best performing risk scoring system in the evaluation of patients with UGIB. Introduction: Food bolus obstruction (FBO) is a common cause of presentation to emergency departments. Data relating to recurrence of FBO and predictors of recurrence are lacking. This study aimed to assess the recurrence rate of FBO, predictors for FB recurrence, management, and outcomes. Methods: We performed a prospective observational study over a 6-year period (January 2011-December 2016) in a tertiary-based hospital. Data on outcomes of all patients who presented with FBO and recurrent episodes requiring emergency endoscopic management were prospectively collected. The primary measured outcomes were recurrence rate of FBO, predictors of recurrent FBO, success rate of esophageal dilatation, and complications. Results: Of the 315 patients (213 male, 102 female; 58.3 ± 18.3 years) with FBO, 208 (66.0%) had underlying pathology, the most frequent being peptic stricture (31%, n = 64), followed by eosinophilic esophagitis (EoE) (24%, n = 50), Schatzki ring (8%, n = 17), esophageal tumor (2%, n = 4), post-surgical stricture (3%, n = 7), and dysmotility (2%, n = 5). Recurrence of FBO occurred in 59 (19%), with a mean presentation of 2.8 per patient. The pathologies underlying recurrence of FBO were peptic stricture (n = 30), EoE (n = 28), and Schatzki ring (n = 1). Of the patients with peptic strictures and EoE, recurrence was significantly more common in those who did not have dilatation at the initial presentation (peptic stricture: 30/43 vs 0/21, P < 0.001; and EoE: 28/33 vs 0/17, P < 0.001). There was no complication from esophageal dilatation. Of those with recurrence of FBO, 14 (24%) were due to failure of follow-up. On multivariate analyses, risk factors for recurrent FBO were underlying EoE (odds ratio [OR], 10.51; 95% CI, 5.37-20.57; P < 0.001), lack of dilatation of peptic or EoE stricture during the first episode (OR, 7.64; 95% CI, 4.09-14.25; P < 0.001), failure of follow-up (OR, 2.21; 95% CI, 1.10-4.43; P < 0.001), and male sex (OR, 2.12; 95% CI, 1.07-4.21; P = 0.03). Conclusion: Recurrence of FBO is relatively common (19%), and risk factors are underlying EoE, lack of dilatation for peptic and EoE strictures, failure of follow-up, and male sex. Optimization of medical treatment for EoE and concurrent dilatation of visible peptic or EoE strictures at the first presentation are helpful to reduce the risk of recurrence. Background: Single-balloon enteroscopy (SBE), in conjunction with capsule enteroscopy (CE), is an established tool in the diagnosis and treatment of small bowel disorders. Data on the quality and patient-centered outcomes of SBE and CE are often derived from academic centers and are lacking in the private health care sector. We report on the effectiveness and quality of SBE in private practice. Methods: Outcomes of all patients who were referred for SBE in 2016 were prospectively collected into a database. Demographics, clinical information, procedural indication, procedural success rate, duration of the procedure, and outcome date were collected and analyzed. Results: A total of 27 patients (11 male; mean age, 64 years) who underwent SBE at two private institutions were studied. Anterograde and retrograde approaches were performed in 22 and five patients, respectively ( Table 1 ). The most common indication for anterograde approach was iron deficiency anemia (n = 19; 70.4.2%); among these patients, 14 had occult bleeding and five had overt bleeding. All of these patients had a CE performed before enteroscopy, of whom 13 (64.7%) had small bowel angioectasia detected, two (11.8%) had small bowel polyps, two (11.8%) had a non-obstructed enteral stricture, one (5.9%) had small bowel ulcer, and one (5.9%) had an inflamed segment of small bowel. In 10 of the 19 patients, the capsule findings were confirmed and treated by the enteroscope. The other indications for anterograde approach were small bowel lesions detected on cross-sectional imaging (n = 2) and endoscopic mucosal abnormalities in one patient. Of the five patients who underwent retrograde SBE, two had failed colonoscopy due to redundant colon and three had abnormality seen on cross-sectional imaging (two with ileal stricture and one ileal polyp). Four of five patients who underwent retrograde SBE had successful enteroscopic therapy. The overall diagnostic yield of SBE was 46.15%; 14 patients had normal findings (no pathology detected), eight had angioectasia treated with heater probe, three had polypectomy, and one stricture was dilated. There were no complications. The overall average procedure time was 67.19 ± 26.97 min; 63.59 min in the anterograde approach (range, 26-103 min) versus 77.25 min in the retrograde approach (range, 44-126 min). The mean depth of intubation was 247.4 and 249.3 cm using the anterograde and retrograde approach, respectively. Conclusions: Our data show that SBE appears to be safe and effective in the diagnosis and treatment of small bowel pathology in private practice. More data are needed to verify these results.
Absence of bile on endoscopy as a predictive factor for suppurative cholangitis in acute calculous cholangitis KH RYU,* SM KIM,* MI KANG, † H-S KOO,* KH SONG,* TH LEE,* KC HUH,* YW CHOI,* YW KANG* *Konyang University Hospital, Daejeon, †
Dankook University Hospital, Cheonan, Korea
Introduction: An impacted bile duct stone is a risk factor for developing acute suppurative cholangitis (ASC). No study has classified biliary obstruction caused by impacted bile duct stones into complete and incomplete obstruction. Complete obstruction would show no bile juice on esophagogastroduodenoscopy (EGD), and it is more likely to be accompanied with ASC than with incomplete obstruction. Methods: We evaluated 191 patients who underwent EGD within 24 hours before endoscopic retrograde cholangiopancreatography (ERCP) for acute calculous cholangitis from January 2012 to August 2016 at Konyang University Hospital. Patients were divided into groups: bile juice present in the stomach or duodenum on EGD (bile (+) group) and no bile juice present (bile (-) group). The presence of biliary pus on the following ERCP was analyzed. We divided patients into acute suppurative calculous cholangitis (ASCC) (n = 26) and acute non-suppurative calculous cholangitis (ANSCC) groups. Predictive markers for ASCC were analyzed. Results: Fifty-five patients (41%) presented with no bile juice on EGD. In 18 patients (32.7%) of the bile (-) group and two (2.5%) of the bile (+) group (P < 0.01), pus could be seen during ERCP. The absence of bile juice on EGD (odds ratio [OR] for ASCC, 6.170; 95% CI, 1.858-20.495) and total bilirubin level (OR for ASCC, 1.232; 95% CI, 1.058-1.436) were independent predictive factors for ASCC. Conclusions: The absence of bile juice on EGD and high total bilirubin level can be predictive markers for ASCC. Performing EGD before ERCP to evaluate the presence of bile juice can be beneficial to predict ASCC and determine the timing of biliary drainage.
Outcomes of percutaneous endoscopic gastrostomy: 6 years of experience at a tertiary hospital J SATCHWELL, F GRIMPEN Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Background: Percutaneous endoscopic gastrostomy (PEG) is a widely employed method to maintain long-term enteral nutrition, which can improve mortality in select patient cohorts. There is increasing use of PEG placement for a wide variety of acute medical conditions where long-term benefits are less certain and risk of early morbidity and mortality may be higher. Such concerns have prompted us to evaluate our institution's patient cohort undergoing PEG insertion and attempt to identify risk factors that may contribute to early morbidity and mortality. Aim: To evaluate complications, early mortality and long-term outcomes in patients undergoing PEG placement at our institution. Methods: Endoscopic procedures for insertion of PEG tubes between January 2011 and March 2017 were identified using electronic endoscopy and medical records at our hospital. Data collected for this retrospective series included the indication for PEG insertion, patient demographics, clinical comorbidities, and endoscopic findings. Early post-procedural complications were also identified. Data on 30-and 90-day post-procedural mortality were also collected. Proportions were compared using Fisher's exact test and continuous variables using Student's t-test. All statistics are reported as a mean ± standard deviation. Results: A total of 548 PEG procedures were performed on 512 patients over a 6-year period at our institution; 404 patients (79%) were male and 107 (21%) were female, with a mean age of 60.1 ± 14.4 years. Median procedural time was 10.7 ± 7.93 minutes. The most common primary indications for PEG insertion were oropharyngeal or laryngeal malignancy (n = 274, 53%), neurogenic dysphagia (including motor neurone disease, myasthenia gravis, and Parkinson's disease) (n = 51, 10%), oropharyngeal dysphagia (n = 54, 10.5%), stroke (n = 21, 4.1%), and recurrent aspiration (n = 9, 1%). Immediate post-procedural complications include peristomal infection treated with oral antibiotics (n = 30, 5.4%), aspiration (n = 21, 3.9%), peristomal collection requiring admission and intravenous antibiotics (n = 18, 3.2%), peristomal bleeding (n = 6, 1%), peritonitis conservatively managed (n = 3), and liver laceration conservatively managed (n = 1). Three patients required early surgical and/or radiological drainage of a PEG-associated collection, with two of these patients dying within 30 days of PEG insertion. Of 512 patients undergoing PEG insertion, 17 (3.1%) died within 30 days of the procedure, with 12 of these patients being hospitalized for other acute illnesses in the lead-up to PEG insertion, 10 suffering from neurogenic dysphagia or stroke as an indication for PEG insertion, and six being bed-bound. In patients dying within 30 days of PEG insertion, the most common causes included aspiration and respiratory failure (n = 11), rapid progression of neurological disease or malignancy (n = 3), and death due to procedure-related infection (n = 2). Thirty-nine patients (7.1%) died within 90 days of PEG placement: 19 (48%) from aspiration-related complications, seven from respiratory failure, and six from disease progression. A higher proportion of patients dying within 90 days of PEG insertion suffered from a neurogenic dysphagia (n = 11, 28%) or stroke (n = 13, 33%) as an indication for PEG insertion compared with all other causes (P < 0.001). Of patients having a PEG inserted due to stroke, 61% died within 90 days of the procedure (n = 17). Conclusion: Significant 30-and 90-day mortality after PEG insertion has been demonstrated in our unselected cohort. A higher proportion of patients dying within 90 days of the procedure suffer from neurological disease and stroke or are hospitalized for acute illness before PEG insertion. These may represent risk factors which, if identified, may avoid unnecessary PEG placement in patients with a short life expectancy.
Outcomes of endoscopy for food bolus impaction: 6 years of experience at a tertiary hospital J SATCHWELL, F GRIMPEN Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Introduction: Food bolus impaction is a common indication for upper endoscopy. A variety of endoscopic techniques have been described to accomplish removal of food boluses, but the effectiveness of different techniques has not been clearly described. We describe a series of patients undergoing endoscopy for food bolus impaction over a 6-year period at our tertiary hospital. Aim: To evaluate the safety and outcomes of endoscopic techniques used in facilitating removal of impacted food boluses. Methods: Upper endoscopies performed for food bolus impaction between January 2011 and May 2017 were identified using electronic endoscopy records at our hospital. Data collected for this series included patient demographic characteristics, endoscopic findings including the type of food bolus identified, location, method of treating the food bolus impaction, procedural time, and subsequent major complications. The cause of the food bolus impaction was identified based on characteristics at endoscopy, histology results from biopsy, and subsequent endoscopic follow-up. Proportions were compared using Fisher's exact test and continuous variables using the Student's t-test. All statistics are reported as a mean ± standard deviation. Results: A total of 255 upper endoscopies for food bolus impaction were performed on 230 patients over a 6-year period at our institution; 170 patients (74%) were male and 60 (26%) were female, with a mean age of 51 ± 18.4 years. Mean procedural time was 23 ± 22.4 minutes. There were 114 endoscopies (46%) performed in the endoscopy suite and 91 (36%) in an operating theater. A total of 181 (71%) were performed within work hours and 74 (29%) after hours. Food impaction was located in the upper esophagus or cricopharynx in 43 cases (16%), mid esophagus in 61 (23%), distal esophagus in 121 (47%), and within an esophageal surgical anastomosis in three. The most common types of food retrieved included steak (30), chicken (18), lamb (5), beef (4), pork (4), and meat not otherwise identified (4) . In eight cases, vegetable material was described in addition to the food bolus. The type of food impacted was not described in 169 cases. Methods of retrieval described include the push technique (n = 53, 20%), net (41, 16%), snare (40, 15.6%), forceps (20, 7%), distal attachment/cap with suction (20, 7%), and tri-graspers (10, 3.9%). Causes of food bolus impaction included eosinophilic esophagitis (EoE) (n = 62, 24%), benign esophageal strictures (n = 38, 19%), erosive gastroesophageal reflux disease (n = 54, 17%), malignancy (n = 23, 9%), achalasia (n = 8, 3%), and Zenker's diverticulum (n = 6, 2%). No obvious pathology was identified in 22 cases (11%). Two cases of perforation after endoscopic intervention were described, both of which were associated with use of a push technique, with EoE as an underlying pathology. Mean procedure time was 19.16 ± 22.6 minutes when a snare was used, 13.24 ± 18.44 minutes for the Roth net, 10.37 ± 12.93 minutes for the push technique, and 8.6 ± 13.42 minutes when a distal cap was used. There was an association between using a distal attachment and a shorter procedural time but this did not reach statistical significance (P < 0.45). During the study period, 18 patients had more than one presentation with food bolus impaction requiring endoscopic therapy, with causes including benign strictures (n = 5), EoE (n = 4), and reflux disease (n = 5). Fourteen of the 18 patients (77%) requiring repeat procedures were over the age of 50 years. Conclusion: A variety of endoscopic techniques for managing food bolus impaction are described in our case series. Application of a push technique should be done with caution, given the complications demonstrated in our case series. Use of a distal cap attachment with suction may be a more time-effective method in managing food bolus impaction, but further investigation is required.
Glasgow-Blatchford score utilization to riskstratify patients with acute non-variceal upper gastrointestinal bleeding for outpatient management S SELVARATNAM, D DE LAS HERAS, F WEILERT Department of Gastroenterology, Waikato Hospital, Hamilton, New Zealand
Introduction: Upper gastrointestinal bleeding (UGIB) is a common presentation to hospital. Risk stratification scores are widely recommended for patients at presentation to plan emergent endoscopic procedures and intervention. Recent literature has recommended the use of a restricted transfusion strategy in the management of these patients. Aim: To assess the performance of the AIMS65, Glasgow-Blatchford score (GBS), and pre-endoscopy Rockall score (PERS) in a New Zealand population of patients with non-variceal UGIB to predict endoscopic intervention and patient outcome. Methods: All adult patients who presented to a tertiary-level hospital with non-variceal UGIB (January 2014-December 2016) were included in a retrospective review of a prospective database and clinical records to evaluate patient demographics, need for intervention (blood transfusion or endoscopic), and mortality. The AIMS65, GBS, and PERS were calculated for each patient using admission data. Results: A total of 402 patients were included (median age, 71 years [range, 16-100]), with male predominance of 59% (n = 216). Ethnic distribution reflected the New Zealand population, with 64% New Zealand European, 22% Maori, and 5% Pacific Islander and Asian origin. Patients presented with melena in 62% and hematemesis in 28%. Of the 224 patients (53%) who received a red blood cell transfusion (median, two units [range, 1-4]), 60% (n = 134) were inappropriately transfused if the restricted transfusion protocol was adhered to, equating to a total additional cost of about NZ$100 000. Upper gastrointestinal endoscopy was performed in 350 patients (87%), 96% within 24 hours of admission, demonstrating a cause for bleeding (positive finding) in 69% of patients. However, endoscopic intervention was required in only 36%, with gastric and duodenal ulceration the most common pathology (29.1% and 20.9%, respectively). Mean hospital stay was longer for patients on blood-thinning medication (4.04 vs 2.88 days, P < 0.001). Our 30-day rebleeding rate was 2.74%, while the 30-day mortality rate was 1.24%. The GBS was superior to the AIMS65 and PERS in predicting a positive endoscopic finding, with an AUROC of 0.78 (P < 0.001). The GBS was also superior in predicting the need for an endoscopic intervention (AUROC, 0.79; P < 0.001). AIMS65 was superior for predicting 30-day mortality (AUROC, 0.97; P < 0.001). Using a GBS cut-off score of 3 or less, 70 patients (17%) were classified as being at low risk of requiring endoscopic treatment, with a negative predictive value of 97.1%.
Conclusion:
The GBS was the best predictor of a positive endoscopic finding and the need for an endoscopic intervention. A GBS cut-off level of 3 or less could be safely used to avoid admission and manage patients with outpatient upper gastrointestinal endoscopy for acute non-variceal UGIB. Applying stringent transfusion criteria would also translate to significant resource savings. Anticardiolipin antibody syndrome has been associated with gastrointestinal ischemia, of which there has only been one reported case of acute esophageal necrosis (AEN) in the literature. 1 We report a case of a 56-year-old woman who presented with unintentional weight loss, lethargy, exertional dyspnea over a month, and a hemoglobin (Hb) level of 41 g/L. She has known type 2 diabetes mellitus, hypertension, and anticardiolipin antibody syndrome. Her regular medications include apixaban, metformin, and perindopril. She was managed with blood transfusion and further investigations, including a computed tomography scan of the abdomen, which showed extensive para-aortic lymphadenopathy. She had a colonoscopy, which revealed a large fungating mass in the ascending colon, with biopsies confirming adenocarcinoma. Subsequently, she underwent a laparoscopic right hemicolectomy, complicated by an episode of hypotension requiring inotropic support in the intensive care unit. On the third post-operative day, nasogastric aspirate surprisingly revealed 500 mL of coffee ground fluid. This was associated with a drop in Hb level from 91 to 58 g/L, prompting an emergency gastroscopy. This revealed a black esophagus involving the entire length of esophagus (Figure 1 ). Biopsies from the esophagus showed necrotic tissue and edematous connective fibrous tissue with dense inflammatory infiltrate. The inflammation involved the underlying smooth muscle (likely muscularis propria), and the small vessels contained luminal thrombi and mural fibrin deposits with scattered inflammatory cells consistent with a diagnosis of AEN. There were no inclusion bodies suggestive of cytomegalovirus or fungal elements. She was kept nil by mouth and managed with high-dose proton pump inhibitors and oral sucralfate. Gastroscopy was repeated a week later, and there was overall improvement with only mild to moderate esophageal inflammation ( Figure 2 ). Repeat esophageal biopsies confirmed only esophagitis with no necrosis. Acute esophageal necrosis is rare and has been associated with infections, volvulus, hyperglycemia, underlying malignancy, gastric outlet obstruction, Stevens-Johnson syndrome, shock, acute alcohol misuse, malnourishment, and hypoperfusion. It has been hypothesized that the condition is a result of multifactorial insult from a combination of local ischemia from hypoperfusion, increased acid exposure, and decreased esophageal clearance, which leads to direct injury with necrosis. 2 Patients with anticardiolipin antibody syndrome may therefore be prone to developing this condition. To our knowledge, this is the second case report of this association and the first case report from Australia.
Endoscopic ultrasound as a predictor and guide to successful endotherapy in chronic pancreatitis P SOMANI, M SHARMA Department of Gastroenterology, Jaswant Rai Specialty Hospital, Meerut, India Background: Pancreatic calculi are a sequelae of chronic pancreatitis (CP) and may obstruct and produce ductal hypertension, leading to pain, the cardinal feature of CP. The rationale for endoscopic treatment of obstructing pancreatic calculi is based on the observation that pain subsides when the stone(s) is removed and drainage of pancreatic secretion is restored. Indications for endotherapy include stones < 5 mm in size, stones in the head of pancreas which are not impacted, and absence of downstream strictures. The assessment before the procedure is done by magnetic resonance cholangiopancreatography (MRCP) or computed tomography (CT). However, problems are encountered during endoscopic retrograde cholangiopancreatography (ERCP) clearance which are not anticipated despite MRCP or CT. The problems are possible impacted stones, hard stones, indeterminate stricture, and change of finding during ERCP. Hence, controversy exists. Endoscopic ultrasound (EUS) can help by providing concordance or discordance with MRCP images and may help in further clarification. 
Endoscopy Upper
Aim: To evaluate the role, feasibility, and management changes of EUS before ERCP in patients planned for endotherapy for CP. Another objective was to evaluate whether EUS features of pancreatic duct (PD) stones can serve as a predictor of successful removal during ERCP. Methods: The data of 412 patients with CP during the study period (2009-2016) were retrospectively analyzed. A total of 143 cases were associated with stones in the head/papillary region of the pancreas. Of these, 75 were excluded and the remaining 68 were evaluated by EUS using a linear/radial echo endoscope before ERCP. Results: Of 68 cases, 48 were associated with hard stones with acoustic shadowing, while 20 were associated with soft stones without acoustic shadowing. In the 20 patients with soft stones, ERCP was successful in 18. In the 48 patients with hard stones, there was failure of endotherapy in 40 patients, which required extracorporeal shock wave lithotripsy (ESWL) or surgery. The remaining eight patients required multiple sessions of ERCP for successful removal. Three patients had ampullary/papillary stones, which were removed with precut sphincterotomy, with immediate relief of pain. Four patients had ventral duct obstruction by calculi and hence underwent ERCP through minor papilla, with successful removal of stones in three patients. In three patients, there were calculi in pancreatic parenchyma and the pancreatic duct simultaneously (ducto-parenchymal stones), and hence, endotherapy was avoided. Three patients had pancreas divisum diagnosed on EUS and hence underwent minor papillotomy with stone removal. Three patients also had biliary obstruction with common bile duct stone/sludge and underwent biliary endotherapy. Four patients had pancreatic mass in head and underwent EUS-fine needle aspiration, with two patients diagnosed with pancreatic cancer and referred for surgery. The remaining two were also referred for surgery. Four patients were found to have strictures on EUS and hence were referred for surgery. The presence of large (≥ 5 mm), hard, immobile stones was a negative predictor of successful endotherapy. Small, ampullary/papillary stones were positive predictors. Conclusions: This study suggests that EUS can differentiate "soft PD stones" (without an acoustic shadow) from "hard PD stones" (with an acoustic shadow). This differentiation can help in predicting successful removal during ERCP. "Hard PD stones" diagnosed on EUS are better managed by ESWL. An EUS can influence important therapeutic decisions before endotherapy and can prevent unsuccessful attempts at ERCP and thus improve overall success and prognosis. An EUS has an additional advantage of making a diagnosis of ampullary/papillary stones and biliary obstruction, which can be treated endoscopically. It can guide whether endotherapy needs to be performed through major or minor papilla. By diagnosing pancreatic tumor/strictures missed on other imaging modalities, EUS allows early surgical reference and hence improves long-term prognosis. It can prevent unsuccessful attempts at endotherapy and its possible risks and costs. We conclude that EUS before endotherapy plays an important role in further management decisions for patients with CP. Introduction: Polyarteritis nodosa (PAN) is an uncommon necrotising, focal segmental vasculitis that affects medium-and small-sized muscular arteries in multiple organs. Vasculitis of the gallbladder is a rare phenomenon, only accounting for 1.6-2.7% of patients with PAN. 1 We report a case of a young man with PAN of the gallbladder mimicking acalculous cholecystitis. Case: A 34-year-old white man presented with a 2-week history of worsening jaundice, intermittent right upper quadrant pain, fevers, dark-colored urine, night sweats, anorexia, and malaise. Liver enzyme tests demonstrated a cholestatic pattern with a bilirubin level of 96 μmol/L, gammaglutamyl transferase of 301 U/L, alkaline phosphatase of 311 U/L, Histology revealed vasculitis in a majority of the small-to medium-sized arteries within the walls of the gallbladder, consistent with PAN ( Figure 1) . He was commenced on 3 days of intravenous methylprednisolone 1 g, followed by 50 mg oral prednisolone, which resolved his symptoms. Discussion: PAN can be localized to the gastrointestinal tract, where the small bowel and gallbladder are most commonly affected, or can more commonly occur systemically, where patients develop systemic symptoms, such as hypertension, myalgia, and cutaneous disease. The diagnosis of PAN can be challenging and warrants a high index of suspicion, as there are no significant clinical manifestations or laboratory markers. Radiological imaging plays a pivotal role in diagnosis, with conventional angiography being considered the gold standard. In gallbladder vasculitis, angiography is often not used, as patients are initially thought to have cholecystitis secondary to cholelithiasis. In such instances, HIDA scan used in conjunction with biopsy have confirmed findings of PAN. Conclusion: Gallbladder vasculitis due to PAN is uncommonly encountered in the Australian population. Clinicians should have a high level of suspicion for vasculitis, especially alongside other differentials like cholecystitis, choledocholithiasis, and malignancy.
